全文获取类型
收费全文 | 2742篇 |
免费 | 111篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 63篇 |
妇产科学 | 63篇 |
基础医学 | 359篇 |
口腔科学 | 15篇 |
临床医学 | 187篇 |
内科学 | 778篇 |
皮肤病学 | 14篇 |
神经病学 | 85篇 |
特种医学 | 15篇 |
外科学 | 76篇 |
综合类 | 29篇 |
预防医学 | 697篇 |
眼科学 | 6篇 |
药学 | 378篇 |
中国医学 | 7篇 |
肿瘤学 | 85篇 |
出版年
2023年 | 144篇 |
2022年 | 71篇 |
2021年 | 145篇 |
2020年 | 187篇 |
2019年 | 137篇 |
2018年 | 186篇 |
2017年 | 194篇 |
2016年 | 209篇 |
2015年 | 212篇 |
2014年 | 321篇 |
2013年 | 236篇 |
2012年 | 74篇 |
2011年 | 66篇 |
2010年 | 141篇 |
2009年 | 128篇 |
2008年 | 27篇 |
2007年 | 64篇 |
2006年 | 48篇 |
2005年 | 31篇 |
2004年 | 13篇 |
2003年 | 11篇 |
2002年 | 26篇 |
2001年 | 31篇 |
2000年 | 13篇 |
1999年 | 24篇 |
1998年 | 23篇 |
1997年 | 21篇 |
1996年 | 28篇 |
1995年 | 12篇 |
1994年 | 11篇 |
1993年 | 7篇 |
1992年 | 3篇 |
1991年 | 2篇 |
1990年 | 7篇 |
1989年 | 3篇 |
1988年 | 4篇 |
排序方式: 共有2860条查询结果,搜索用时 15 毫秒
1.
2.
3.
《Vaccine》2019,37(31):4382-4391
Cancer-associated fibroblasts (CAFs), major components of the tumor microenvironment (TME), promote tumor growth and metastasis and inhibit the anti-tumor immune response. We previously constructed a DNA vaccine expressing human FAPα, which is highly expressed by CAFs, to target these cells in the TME, and observed limited anti-tumor effects in the 4T1 breast cancer model. When the treatment time was delayed until tumor nodes formed, the anti-tumor effect of the vaccine completely disappeared. In this study, to improve the safety and efficacy, we constructed a new FAPα-targeted vaccine containing only the extracellular domain of human FAPα with a tissue plasminogen activator signal sequence for enhanced antigen secretion and immunogenicity. The number of CAFs was more effectively reduced by CD8+ T cells induced by the new vaccine. This resulted in decreases in CCL2 and CXCL12 expression, leading to a significant decrease in the ratio of myeloid-derived suppressor cells in the TME. Moreover, when mice were treated after the establishment of tumors, the vaccine could still delay tumor growth. To facilitate the future application of the vaccine in clinical trials, we further optimized the gene codons and reduced the homology between the vaccine and the original sequence, which may be convenient for evaluating the vaccine distribution in the human body. These results indicated that the new FAPα-targeted vaccine expressing an optimized secreted human FAPα induced enhanced anti-tumor activity by reducing the number of FAPα+ CAFs and enhancing the recruitment of effector T cells in the 4T1 tumor model mice. 相似文献
4.
5.
《Molecular immunology》2015,68(2):492-500
Although intranasal vaccination has been shown to be effective for the protection against inhalational anthrax, establishment of long-term immunity has yet to be achieved. Here, we investigated whether intranasal immunization with recombinant protective antigen (rPA) of Bacillus anthracis induces immunological memory responses in the mucosal and systemic compartments. Intranasal immunization with rPA plus cholera toxin (CT) sustained PA-specific antibody responses for 6 months in lung, nasal washes, and vaginal washes as well as serum. A significant induction of PA-specific memory B cells was observed in spleen, cervical lymph nodes (CLNs) and lung after booster immunization. Furthermore, intranasal immunization with rPA plus CT remarkably generated effector memory CD4+ T cells in the lung. PA-specific CD4+ T cells preferentially increased the expression of Th1- and Th17-type cytokines in lung, but not in spleen or CLNs. Collectively, the intranasal immunization with rPA plus CT promoted immunologic memory responses in the mucosal and systemic compartments, providing long-term immunity. 相似文献
6.
8.
9.
《Vaccine》2020,38(32):4940-4943
To determine the duration of immunity provided by the Hepatitis A vaccination (HepA), we evaluated a cohort of participants in Alaska 20 years after being immunized as infants. At recruitment, participants received two doses of inactivated HepA vaccine on one of three schedules. We conducted hepatitis A antibody (anti-HAV) testing for participants at the 20-year time-point. Seventy-five of the original 183 participants (41%) were available for follow-up. The overall anti-HAV geometric mean concentration was 29.9 mIU/mL (95% CI 22.4 mIU/mL, 39.7 mIU/mL) and 50 participants (68%) remained seropositive (titer ≥ 20 mIU/mL). Using a fractional polynomial model, the predicted percent seropositive at 25 years was 55.3%, 49.8% at 30 years and 45.7% at 35 years, suggesting that the percent sero-positive could drop below 50% earlier than previously expected. Further research is necessary to understand if protection continues after seropositivity diminishes or if a HepA booster dose may become necessary. 相似文献
10.